|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/454 | |
| A61P 25/18 |
| (11) | Number of the document | 3345603 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18152636.9 |
| Date of filing the European patent application | 2013-03-14 | |
| (97) | Date of publication of the European application | 2018-07-11 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-18 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261610664 P | 2012-03-14 | US |
| (72) |
PHADKE, Deepak, US
WOLFGANG, Curt D., US
POLYMEROPOULOS, Mihael H., US
FEENEY, John Joseph, US
BIRZNIEKS, Gunther, US
|
| (73) |
Vanda Pharmaceuticals Inc.,
2200 Pennsylvania Ave NW Suite 300-E, Washington, DC 20037,
US
|
| (54) | ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS |
| ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS |